Colleges
-
Unlocking the potential of patient-derived organoids for personalized sarcoma treatment
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have developed the largest collection of sarcoma patient-derived organoids to date that can help improve understanding of the disease and better identify therapies that are most likely to work for each individual patient. The approach, described in Cell Stem Cell, uses patients’ own tumor cells to replicate the unique characteristics of…
Read More » -
Dr. Robert Ojiambo
“There is existing evidence that if you spend time in sedentary behavior, you are conserving energy, and this conserved energy has negative health implications.” Dr. Robert Ojiambo joined Weill Cornell Medicine-Qatar (WCM-Q) in July 2024 and currently holds the position of Associate Professor of Physiology and Biophysics. His research focuses on human energy balance and the relationship between energy intake,…
Read More » -
WCM-Q program promotes professionalism in medical education in a highly diverse culture
A symposium and webinar series offered by the Division of Continuing Professional Development at Weill Cornell Medicine-Qatar (WCM-Q) addressed the challenges associated with fostering professionalism in medical education in Qatar’s highly diverse multicultural context. The symposium, titled Fostering Professionalism in Medical Education: Exploring Effective Approaches for Diverse Learners, features a full day of interactive sessions led by highly experienced WCM-Q…
Read More » -
Novel Intraoperative Imaging Device Advances Precision Surgery for Patients with Cancer
The Dynamic Optical Contrast Imaging (DOCI) device is a revolutionary, non-invasive imaging system that utilizes advanced high-speed cameras and LED lights to delineate margins between malignant and healthy tissue in real-time. This pioneering imaging device, created by a UCLA Health surgeon, does not require the use of injectables or dyes like traditional cancer-identifying devices. The DOCI system was created by…
Read More » -
Why are more young people getting cancer? What to know as cases rise
It’s a mystery doctors and scientists have yet to solve: More younger adults are getting diagnosed with cancer. The number of early onset cancer cases — those that occur in adults under age 50 — is rising by 1% to 2% annually, according to the American Cancer Society. An analysis of global health data published in the journal BMJ Oncology predicts…
Read More » -
UCLA Health launches clinical trial using personalized cancer vaccine to tackle aggressive brain tumors in adolescents and young adults
UCLA Health is leading a groundbreaking clinical trial to combat one of the most aggressive forms of brain cancer with a personalized cancer vaccine. This pioneering study represents UCLA Health’s inaugural human trial for a vaccine specifically targeting diffuse hemispheric glioma, a malignant brain tumor predominantly affecting adolescents and young adults. The trial, funded by the Department of Defense, the…
Read More » -
‘A one-and-done treatment’: UChicago Medicine among the first in the U.S. to use TIL therapy for advanced skin cancer
For 15 years, Alla Pinzour traveled the country seeking treatments for her advanced melanoma. Some would bring temporary remission, but her skin cancer always returned. “Surgeries, chemo, radiation — you name it, I had it done,” she said. “Nothing seemed to work.” By early 2024, Pinzour’s skin cancer had spread to other places in her body, including her lungs and…
Read More » -
WCM-Q to host second alumni-led primary care conference
Weill Cornell Medicine-Qatar (WCM-Q) will host its second annual Updates in Primary Care conference on November 29 and 30 in Doha, Qatar. The conference, titled ‘Updates in Primary Care: Specialist-Led Case-Based Discussions Highlighting the Latest Evidence and Best Clinical Practice – 2024,’ reflects WCM-Q’s commitment to delivering cutting-edge, practical education. Organized entirely by graduates of the college, the two-day conference…
Read More » -
Theranostics treatments for cancer underway at UCLA Health
UCLA Health’s new leading-edge theranostics center, using targeted radioactive drugs to treat advanced cancer, is now open. Offering state-of-the-art facilities and expertise, the 3,000-square-foot Outpatient Theranostics Center in Westwood, part of the UCLA Health Jonsson Comprehensive Cancer Center, specializes in radiopharmaceutical therapy. It is one of the largest of its kind in the United States, according to Jeremie Calais, MD,…
Read More » -
Ghaith Abu-Zeinah, M.D.
Assistant Professor of Medicine, Division of Hematology and Oncology, Weill Cornell Medicine, New York Assistant Attending Physician, NewYork-Presbyterian Hospital Visiting Faculty Member, Weill Cornell Medicine-Qatar “The general symptoms of MPNs include fatigue, headaches, weight loss, and night sweats.” Dr. Ghaith Abu-Zeinah is an Assistant Professor of Medicine in the Division of Hematology and Oncology at Weill Cornell Medicine in New…
Read More »